Join the Inbrija group to help and get support from people like you.
Inbrija News
Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease
THURSDAY, April 11, 2024 – Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a...
FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease
ARDSLEY, N.Y.--(BUSINESS WIRE) December 21, 2018 --Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approved Inbrija™ for intermittent treatment of OFF episodes in ...
Ask a question
To post your own question to this support group, sign in or create an account.